Concepedia

Chana Weinstock

CW

20

Publications

1.3K

Citations

15

H-Index

1977

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

National Cancer Institute

Center for Devices and Radiological Health

Weill Cornell Medicine

Chana Weinstock is an author at United States Food and Drug Administration specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1977–2024

20

Publications

20

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

V. Ellen Maher, Laura L. Fernandes, Chana Weinstock et al. · Journal of Clinical Oncology · 2019 · 336 citations

FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma

Elaine Chang, Chana Weinstock, Lijun Zhang et al. · Clinical Cancer Research · 2020 · 173 citations · Full text

, , +14

FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease–Associated Tumors

Jaleh Fallah, Michael H. Brave, Chana Weinstock et al. · Clinical Cancer Research · 2022 · 149 citations · Full text

, , +21

U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non–Small Cell Lung Cancer

Chana Weinstock, Sean Khozin, Daniel L. Suzman et al. · Clinical Cancer Research · 2017 · 135 citations · Full text

Osimertinib for the Treatment of Metastatic EGFR T790M Mutation–Positive Non–Small Cell Lung Cancer

Sean Khozin, Chana Weinstock, Gideon M. Blumenthal et al. · Clinical Cancer Research · 2016 · 80 citations · Full text

Rows per page

1–5 of 20